Confirmed Sponsors & Exhibitors

Confirmed Sponsors

BRONZE LEVEL

 

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Medela
Medela Healthcare innovates and provides medical vacuum technology solutions for lifesaving treatments and advancement of patient care. Thopaz+ takes chest drainage therapy to a new level of care. Clinical data has demonstrated that Medela’s chest drainage therapy improves outcomes and streamlines the delivery of care.
Medela is headquartered in Switzerland and has 1800 employees and 18 subsidiaries worldwide, distributing its products to more than 100 countries.

 

SUPPORTER LEVEL

BayerBayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. Bayer’s oncology franchise now includes three oncology products and several other compounds in various stages of clinical development. Together, these products reflect the company’s approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated.

 

MyriadMyriad myPlan® Lung Cancer is a molecular prognostic test that measures the expression of cell cycle progression genes to provide an accurate assessment of cancer aggressiveness in patients with early-stage non-small cell lung adenocarcinoma. Current medical society guidelines rely on cancer stage and subjective high risk features to determine lung cancer treatment. Two patients with the same lung cancer stage may have very different estimates of mortality risk when tumor aggressiveness is taken into account. MyPlan® Lung Cancer prognostic score combines molecular information with cancer stage to better predict the five-year risk of lung cancer-specific death than stage alone. Gaining insight into tumor aggressiveness will also help determine if surgery alone is sufficient, or if more aggressive treatment is needed.

Confirmed Exhibitors

Medela
Medela Healthcare innovates and provides medical vacuum technology solutions for lifesaving treatments and advancement of patient care. Thopaz+ takes chest drainage therapy to a new level of care. Clinical data has demonstrated that Medela’s chest drainage therapy improves outcomes and streamlines the delivery of care.
Medela is headquartered in Switzerland and has 1800 employees and 18 subsidiaries worldwide, distributing its products to more than 100 countries.

ScanlanHighest quality surgical products designed and manufactured by the Scanlan family since 1921. Over 3000 titanium and stainless steel instrument designs. Full line SCANLAN® VATS Thoracoscopic instruments for multi-port and uniportal VATS procedures including – SCANLAN® Dennis Rib Cutter, SCANLAN® Rocco Nodule Clamps, SCANLAN® D’Amico Clamps, Suctions, Biopsy Forceps; SCANLAN® Gonzalez-Rivas Dissector, Lung Grasper; Khan Decortication Grasper, Chitwood Knot Pusher. Some selections available in longer and shorter lengths.
<br\>

  Since 1999, Redax has established itself as a leading medical devices supplier, offering a unique and innovative solution of Drainahe Systems based on expertise honed over its 18 years of excellence. We combine experience and innovation with the ability to portary clinical requirements, through continuous cooperation with physicians, engineers and opinion leaders. We are the leader in Drains market with our complete competitive range which includes Thoracic Drainahe Systems, Autotransfusion Devices and Silicone Drains.

AME Publishing Company is a globally active open access publisher specializing in the publication of medical journals and books across the broad spectrum of science, technology and medicine. It is known for its diverse and innovative publication approaches in promoting and expediting scientific research. Its library of products includes medical journals, books, academic activities, electronic and web-based media, and a variety of academic platforms.

Switch To Full Site